I am a neuroscientist of Christian belief who - with his family (+ two kids) - moved to Australia in 2005. Working at UQ as a professor in Alzheimer’s research.
Published in Brain: https://t.co/MFTX2lcivF
Our new data suggest that anti-Tau immunisation works towards restoring homeostasis, presenting quantitative proteomics as a viable strategy to validate therapeutic interventions in preclinical models.
We are pleased to announce a new publication (Leinenga et al., Molecular Psychiatry 2024) from our team which shows in Alzheimer's mice that ultrasound on its own, without blood-brain barrier opening and in the absence of clearing amyloid, can improve cognitive functions.
Where does tumor antigen go after histotripsy? Our new Theranostics paper shows it complexes with DAMP(s), flows to the lymph node, and activates the cDCs that gobble it up. Critical info for optimizing FUS & immunotherapy. https://t.co/4CFRomC91D @FUSFoundation@UVABME
📢 Calling all Australian basic scientists interested in neurodegeneration!!
Registration and abstracts are now open for #CAMAND23, a new conference focused on molecular mechanisms: https://t.co/z82uPKlCxi
Join us in Brisbane; Dec 3-4th 2023
@AusNeuroSoc@BrainMind_Usyd
Warm congratulations to my senior postdoc and Research team leader "Exosomes and tau pathology", Dr Juan Carlos Polanco, who has been invited to speak in Rome on the role of extracellular vesicles and underlying mechanisms in neurological disorders and brain injury.
Brain Ponderings Podcast:
Pondering Ultrasound Treatments for Neuromodulation and Brain Disorders with Jürgen Götz
Spotify: https://t.co/QPG5YIW2Oa
Youtube: https://t.co/Loj7w2kgZ1
Interviewed by Mark P. Mattson, former Chief of the Lab. of Neuroscience at NIH
Our study showing that ATFS-1 acts as a molecular switch to prioritise mtDNA repair over expression, thereby reducing age-dependent mtDNA damage, is out today in @NatureCellBio !
Congrats Michael on your paper! @Michaeldcy1@QldBrainInst
https://t.co/MLkMVUiNkC
Huge congratulations to Adam Briner - my first student cosupervised with @AustraliaGoetz to graduate. He has accepted the Azrieli postdoctoral fellowship and will join @WeizmannScience in November.
Focused #ultrasound mediated blood-brain barrier-opening study in #Alzheimers disease patients by Ali Rezai's team suggests the existence of a brain-wide perivenous fluid efflux route in humans.
Fundamental research is not driven by commercial/practical considerations, but by sheer scientific curiosity.
This type of research has laid the foundations for many of today's most important innovations.
Modern economies can't afford to invest exclusively in applied research.
The #FUSFoundation had its 2nd FUS-AD (#Alzheimer's disease) workshop since 2015 in Washington DC, close to the Arlington airport. Coming up with recommendations how to move the field forward and going home inspired. Thank you, #FUSFoundation.
Move over APOE3 Christchurch—a new protective variant has arrived. A point mutation in the ApoE receptor-binding Reelin enabled two siblings to stave off their autosomal-dominant #Alzheimers for 20 years past expected age of onset. @UdeA@MassGeneralNews https://t.co/hQ7anx4XXg